FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

326121004: Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
466211016 Dinoprostone 3mg vaginal tablet en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
718819010 Dinoprostone 3mg vaginal tablet (substance) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
1190961012 Dinoprostone 3mg vaginal tablet (product) en Fully specified name Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3674336014 Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3674337017 Dinoprostone 3 mg vaginal tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3674338010 Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4651841000005116 dinoproston 3 mg vaginaltablet da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dinoprostone 3 mg vaginal tablet Is a Dinoprostone-containing product in vaginal dose form false Inferred relationship Some
Dinoprostone 3 mg vaginal tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Prostaglandin PGE>2< false Inferred relationship Some
Dinoprostone 3 mg vaginal tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Prostaglandin E>1< false Inferred relationship Some
Dinoprostone 3 mg vaginal tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dinoprostone (substance) false Inferred relationship Some
Dinoprostone 3 mg vaginal tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Posterior pituitary hormone false Inferred relationship Some
Dinoprostone 3 mg vaginal tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Alprostadil false Inferred relationship Some
Dinoprostone 3 mg vaginal tablet Has manufactured dose form Vaginal dose form (dose form) false Inferred relationship Some
Dinoprostone 3 mg vaginal tablet Has manufactured dose form Vaginal tablet true Inferred relationship Some
Dinoprostone 3 mg vaginal tablet Has presentation strength denominator value en false Inferred relationship Some 1
Dinoprostone 3 mg vaginal tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 1
Dinoprostone 3 mg vaginal tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Dinoprostone (substance) true Inferred relationship Some 1
Dinoprostone 3 mg vaginal tablet Has presentation strength numerator value tre false Inferred relationship Some 1
Dinoprostone 3 mg vaginal tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Dinoprostone 3 mg vaginal tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 1
Dinoprostone 3 mg vaginal tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Dinoprostone (substance) true Inferred relationship Some 1
Dinoprostone 3 mg vaginal tablet Count of base of active ingredient en false Inferred relationship Some
Dinoprostone 3 mg vaginal tablet Is a Dinoprostone only product in vaginal dose form true Inferred relationship Some
Dinoprostone 3 mg vaginal tablet Plays role Oxytocic therapeutic role (role) false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

GB English

US English

Back to Start